Published by Iain Gilbert on 4th July 2025
(Sharecast News) - Drugmaker AstraZeneca said on Friday that its Imfinzi asset has been approved in the EU as the first and only perioperative immunotherapy for muscle-invasive bladder cancer.
URL: http://www.digitallook.com/dl/news/story/35196252/...